Early-Onset Parkinsonism Is a Manifestation of the PPP2R5D p.E200K Mutation.
Kim CY. et al, (2020), Ann Neurol, 88, 1028 - 1033
Reply to "PPP2R5D genetic mutations and early-onset parkinsonism".
Kim CY. et al, (2020), Ann Neurol
Inhibition of the SUV4-20 H1 histone methyltransferase increases frataxin expression in Friedreich's ataxia patient cells.
Vilema-Enríquez G. et al, (2020), J Biol Chem
Next generation sequencing using phenotype-based panels for genetic testing in inherited retinal diseases.
Shah M. et al, (2020), Ophthalmic Genet, 41, 331 - 337
Whole-genome sequencing of patients with rare diseases in a national health system.
Turro E. et al, (2020), Nature, 583, 96 - 102
Association of Clinical and Genetic Heterogeneity With BEST1 Sequence Variations
Shah M. et al, (2020), JAMA Ophthalmology, 138, 544 - 544
Evidence for 28 genetic disorders discovered by combining healthcare and research data
Kaplanis J. et al, (2020), Nature
Implementation of a genomic medicine multi-disciplinary team approach for rare disease in the clinical setting: a prospective exome sequencing case series
Taylor J. et al, (2019), Genome Medicine, 11
Finding Diagnostically Useful Patterns in Quantitative Phenotypic Data.
Aitken S. et al, (2019), Am J Hum Genet, 105, 933 - 946
The PREGCARE study: precision genetic counselling via personalised evaluation of recurrence risk for families with a child affected by a disorder caused by a de novo mutation
Abdullah UB. et al, (2019), EUROPEAN JOURNAL OF HUMAN GENETICS, 27, 1101 - 1102
A clinical diagnostic algorithm for early onset cerebellar ataxia.
Brandsma R. et al, (2019), Eur J Paediatr Neurol, 23, 692 - 706
A case-note review of continued pregnancies found to be at a high risk of Huntington's disease: considerations for clinical practice.
Wadrup F. et al, (2019), Eur J Hum Genet, 27, 1215 - 1224
Evaluation of next generation sequencing panels in adult-onset hereditary neurological disorders
Scaber J. et al, (2019), EUROPEAN JOURNAL OF NEUROLOGY, 26, 334 - 334
Heterozygous Variants in KMT2E Cause a Spectrum of Neurodevelopmental Disorders and Epilepsy
O’Donnell-Luria AH. et al, (2019), The American Journal of Human Genetics, 104, 1210 - 1222
Meaningful and Measurable Health Domains in Huntington's Disease: Large-Scale Validation of the Huntington's Disease Health-Related Quality of Life Questionnaire Across Severity Stages.
Ho AK. et al, (2019), Value Health, 22, 712 - 720
Germline selection shapes human mitochondrial DNA diversity.
Wei W. et al, (2019), Science (New York, N.Y.), 364
Author Correction: CHD3 helicase domain mutations cause a neurodevelopmental syndrome with macrocephaly and impaired speech and language.
Snijders Blok L. et al, (2019), Nat Commun, 10
Bi-allelic Loss-of-Function CACNA1B Mutations in Progressive Epilepsy-Dyskinesia
Gorman KM. et al, (2019), The American Journal of Human Genetics, 104, 948 - 956
Clinical application of next-generation sequencing to the practice of neurology.
Rexach J. et al, (2019), Lancet Neurol, 18, 492 - 503